Results 51 to 60 of about 1,890 (188)
Hemoadsorption by CytoSorb in septic patients: a case series [PDF]
Critical Care, 2017 Septic shock, defined as life-threatening organ dysfunction caused by a dysregulated host response to infection, is a highly lethal condition that causes substantial morbidity and mortality among critically ill patients. One of the hallmarks of sepsis is the excessive release of cytokines and other inflammatory mediators causing refractory hypotension,
Klaus Kogelmann +3 more
openaire +3 more sources
Biomedicines, 2022 Background: Sepsis is often associated with liver dysfunction, which is an indicator of poor outcomes. Specific diagnostic tools that detect hepatic dysfunction in its early stages are scarce.
Janina Praxenthaler +6 more
doaj +1 more source
Pharmacology Research & Perspectives, 2021 Both antiviral treatment with remdesivir and hemoadsorption using a CytoSorb® adsorption device are applied in the treatment of severe COVID‐19. The CytoSorb® adsorber consists of porous polymer beads that adsorb a broad range of molecules, including ...
Paul Biever +7 more
doaj +1 more source
Indian Journal of Critical Care Medicine, 2015 Sir, We read the case report “use of a novel hemadsorption device for cytokine removal as adjuvant therapy in a patient with septic shock with multi-organ dysfunction: A case study” by Basu et al.[1] with great interest. We would like to share our experiences with a similar patient in our Intensive Care Unit and discuss some of the intriguing ...
Pattnaik, Saroj Kumar +1 more
openaire +3 more sources
Critical Care, 2023 Background The CytoSorb hemoadsorption device has been demonstrated to be capable of clearing inflammatory cytokines, but has not yet been shown to attenuate plasma cytokine concentrations.
Aron Jansen +4 more
doaj +1 more source
CytoSorb® usage in a dual antiplatelet agent treated patient during CABG and broken guidewire retrieval from right coronary artery ostium [PDF]
International Journal of Medical Device and Adjuvant Treatments, 2022 Objective: We report a case of a patient undergoing Open Coronary Artery Bypass Graft Surgery (CABG) with CytoSorb® under dual antiplatelet therapy (DAPT) with a broken guidewire in RCA ostium.
N. Kumar, V. Keshri, R. Bhuyan
doaj +1 more source
Opportunities, controversies, and challenges of extracorporeal hemoadsorption with CytoSorb during ECMO [PDF]
Artificial Organs, 2021 AbstractExtracorporeal membrane oxygenation (ECMO) is frequently used in many centers around the globe for various indications. However, prognosis is often poor even with all supportive therapies, and in many cases, clinical deterioration is associated with inflammation.
Napp, L. Christian +4 more
openaire +3 more sources
Interleukin-6 Extraction Ratios During Prolonged CytoSorb Hemoadsorption Depend on Procedural Blood Flow [PDF]
Frontiers in MedicineJakob Gubenšek +2 more
exaly +2 more sources
Journal of Translational Medicine, 2017 Background Ex-vivo normothermic perfusion strategies are a promising new instrument in organ transplantation. The perfusion conditions are designed to be protective however the artificial environment can induce a local inflammatory response.
Sarah A. Hosgood +4 more
doaj +1 more source
, 2023 Introduction. Critically ill patients with inflammatory dysregulation and organ disfunction may benefit from blood purification, although the use of this technique has not been described in large case series.
Belletti A. (16875384) +7 more
core +1 more source